Sonoma Pharmaceuticals Inc banner

Sonoma Pharmaceuticals Inc
F:O8Z3

Watchlist Manager
Sonoma Pharmaceuticals Inc Logo
Sonoma Pharmaceuticals Inc
F:O8Z3
Watchlist
Price: 2.72 EUR Market Closed
Market Cap: €51.7m

Intrinsic Value

O8Z3 doesn't have a meaningful market cap.

The intrinsic value for Sonoma Pharmaceuticals Inc (O8Z3) under the Base Case is 8.63 EUR. Compared with the current market price of 2.72 EUR, the stock appears Undervalued by 68% .

Based on two methods:

Both DCF and multiples point to undervaluation.

O8Z3 Intrinsic Value
Base Case
8.63
Undervaluation 68%
Intrinsic Value
Price €2.72
Monitor O8Z3
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €6.9
Get notified when the price drops into your buy zone
Intrinsic Value €8.63
Margin of Safety 20% €6.9
Current Price €2.72
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about O8Z3?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is O8Z3 valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Sonoma Pharmaceuticals Inc.

Explain Valuation
Alternatives to O8Z3

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

SNOA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one O8Z3 stock?

The intrinsic value for Sonoma Pharmaceuticals Inc (O8Z3) under the Base Case is 8.63 EUR.

Is O8Z3 stock undervalued or overvalued?

Compared with the current market price of 2.72 EUR, the stock appears Undervalued by 68% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett